Clinical development

During the clinical development phase, RSSL works with clients to validate methods and establish control of processes for both small and large molecule drug candidates.


When it comes to clinical development, it is important to determine the potency, identity, impurities and safety profile of drug candidates, and develop validation methods to maintain consistency and control during manufacturing. 


To support you with this, RSSL can help you ensure specificity, linearity, accuracy and precision throughout drug development, as well as robustness in your scientific process. By cooperating and collaborating with industry partners, we can provide all the services you need. This includes analysis of how the drug product is affected by changing vessels, methods and processes. This can be used for future manufacturing and before going to regulators. We also provide training and consultancy to ensure regulatory needs are continually met, including offering excellent support for streamlining processes. 

Contact us

Need to get in touch? Either complete the enquiry form or call us:

Switchboard: +44 (0)118 918 4000

Customer Services: +44 (0)118 918 4076

We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.